Filter Results:
(763)
Show Results For
- All HBS Web
(1,409)
- People (2)
- News (339)
- Research (763)
- Events (2)
- Multimedia (5)
- Faculty Publications (389)
Show Results For
- All HBS Web
(1,409)
- People (2)
- News (339)
- Research (763)
- Events (2)
- Multimedia (5)
- Faculty Publications (389)
Sort by
- 29 Sep 2015
- First Look
September 29, 2015
Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=49708 Published first online September 16, 2015 Journal of the American Medical Informatics Association Incorporating Longitudinal Pediatric Patient-centered Outcome Measurement into the Clinical Workflow... View Details
Keywords: Sean Silverthorne
- October 2020 (Revised November 2023)
- Case
COVID-19 Testing at Everlywell
By: Jeffrey J. Bussgang and Olivia Hull
In March 2020, as COVID-19 spreads rapidly across the U.S., Everlywell founder Julia Cheek considers how to respond as a small start-up specializing in at-home lab testing. After making dramatic budget cuts, she decides to pivot the organization to address the... View Details
Keywords: Entrepreneurship; Business Strategy; Venture Capital; Health Care and Treatment; Health Disorders; Leading Change; Technology Adoption; Digital Platforms; Competitive Strategy; Science; Adaptation; Corporate Social Responsibility and Impact; Crisis Management; Social Entrepreneurship; Ethics; Government Legislation; Health; Health Testing and Trials; Health Pandemics; Health Industry; Health Industry; Health Industry; Texas; United States
Bussgang, Jeffrey J., and Olivia Hull. "COVID-19 Testing at Everlywell." Harvard Business School Case 821-001, October 2020. (Revised November 2023.)
- July 2013
- Case
Amul Dairy
By: Ray Goldberg and Ian McKown Cornell
In 2013, Rahul Kumar, the managing director of Amul dairy, India's leading dairy firm, had to decide how to position his firm for the future in light of India's growing population and demand for dairy. How could he maintain the firm's cooperative structure, address the... View Details
Keywords: Agribusiness; Dairy; Policy; Corporate Strategy; Nutrition; Agriculture and Agribusiness Industry; India
Goldberg, Ray, and Ian McKown Cornell. "Amul Dairy." Harvard Business School Case 914-405, July 2013.
- January 2025
- Supplement
Creating Value by Splitting Aster (B): Can One Minus One Equal Two?
By: V.G. Narayanan and Kairavi Dey
Keywords: Corporate Governance; Corporate Accountability; Leadership; Change Management; Mergers and Acquisitions; Health Industry; Asia; India; Middle East; United Arab Emirates
Narayanan, V.G., and Kairavi Dey. "Creating Value by Splitting Aster (B): Can One Minus One Equal Two?" Harvard Business School Supplement 125-070, January 2025.
- 30 Sep 2002
- Research & Ideas
Use the Psychology of Pricing To Keep Customers Returning
speak. The net result is that consumers are more likely to consume when a price is vivid and fresh than when it is obscured or distant. In the case of a health club, this means that members are more likely to go to the gym right after... View Details
Keywords: by Manda Mahoney
- 13 Feb 2013
- Research & Ideas
5 Weight Loss Tips From Behavioral Economists
Leslie John and Michael Norton conducted field research in which office employees at a large corporation had the option to work at walkstations—standing desks attached to slow-moving treadmills. The researchers kept track of how many... View Details
Keywords: by Carmen Nobel
- 08 Sep 2020
- Sharpening Your Skills
Capitalism Works Better When I Can See What You're Doing
corrupt company. Why American Health Care Needs Its Own SECThe United States needs a health care equivalent of the Securities and Exchange Commission to increase transparency and competition. But sometimes a... View Details
Keywords: by Sean Silverthorne
- November 2011 (Revised February 2012)
- Case
China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise
By: Vicki Sato, Christoph Jaeker and Pooja Mehta Solanki
As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the... View Details
Keywords: Globalized Firms and Management; Research; Corporate Strategy; Health Industry; Health Industry; China
Sato, Vicki, Christoph Jaeker, and Pooja Mehta Solanki. "China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise." Harvard Business School Case 612-048, November 2011. (Revised February 2012.)
- 15 Aug 2006
- First Look
First Look: August 15, 2006
contingent reserves, and reserve dependent output costs. Download working paper: http://www.hbs.edu/research/pdf/07-010.pdf Corporate Governance and Networks: Bankers in the Corporate Networks of Brazil,... View Details
Keywords: Sean Silverthorne
- June 2024
- Supplement
Legacy Partners (A)
By: Richard S. Ruback and Royce Yudkoff
Instructors should consider the timing of making videos available to students, as they may reveal key case details.
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Keywords: Acquisition; Small Business; Cost vs Benefits; Decisions; Corporate Entrepreneurship; Leadership Style; Leading Change; Business or Company Management; Problems and Challenges; Health Care and Treatment; Health Disorders; Medical Specialties; Nutrition; Supply Chain Management; Growth Management; Health Industry; Health Industry; Health Industry; United States; California
Ruback, Richard S., and Royce Yudkoff. "Legacy Partners (A)." Harvard Business School Multimedia/Video Supplement 224-725, June 2024.
- February 2024
- Teaching Note
Compass Pathways: Pioneering Psychedelic Treatment
By: Tiona Zuzul
Teaching Note for HBS Case No. 724-412. View Details
- 11 Feb 2019
- Research & Ideas
The Business of Saving the Planet
Roundtable, 200 powerful CEOs said corporations should widen their missions beyond just maximizing profits for shareholders. These Entrepreneurs Take a Pragmatic Approach to Solving Social ProblemsUsing business to create social change... View Details
- 25 Oct 2016
- First Look
October 25, 2016
companies committed to making positive contributions to health and wellness. Focusing on four interconnected areas of corporate impact, it not only discusses the business imperative of promoting a healthier... View Details
Keywords: Sean Silverthorne
- September 2001 (Revised January 2002)
- Case
The American Medical Association-Sunbeam Deal (C): Denouement
By: Ashish Nanda and Kimberly A. Haddad
On September 5, 1997, the American Medical Association(AMA) withdrew from a contract with Sunbeam Corporation, the maker of small home appliances. Sunbeam sued the AMA to pay for the damages or to comply with the contract. The fracas led to the dismissal of three top... View Details
Keywords: Medical Services; Appliances; Lawsuit; Litigation; Professionalism; Contracts; Corporate Accountability; Organizations; Lawsuits and Litigation; Health Industry; Health Industry; United States
Nanda, Ashish, and Kimberly A. Haddad. "The American Medical Association-Sunbeam Deal (C): Denouement." Harvard Business School Case 802-091, September 2001. (Revised January 2002.)
- February 2025
- Case
Abiomed: Clinical Trials and Tribulations
By: Satish Tadikonda, Faith Robertson and William Marks
After receiving 510(k) clearance for the Impella 2.5 device, Abiomed had proceeded to conduct a premarket approval (PMA) process as well to prove clinical superiority, earn greater protection, and extend commercial runway. However, in the middle of the clinical trial... View Details
Keywords: Corporate Disclosure; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Launch; Medical Devices and Supplies Industry
Tadikonda, Satish, Faith Robertson, and William Marks. "Abiomed: Clinical Trials and Tribulations." Harvard Business School Case 825-096, February 2025.
- January 2024 (Revised October 2024)
- Case
DO & CO: Crafting Luxury in the Fast Lane (A)
By: Juan Alcácer, Esel Cekin, Michael Lee and Noah Roberson
In July 2023, Attila Dogudan, the chairman of DO & CO, a renowned international catering firm, found himself in a deep conversation with his two sons about a potential new venture: catering for the Las Vegas Grand Prix, a significant step beyond their 31-year history... View Details
Keywords: Decision Choices and Conditions; Health Pandemics; Opportunities; Corporate Strategy; Luxury; Food and Beverage Industry; Las Vegas
Alcácer, Juan, Esel Cekin, Michael Lee, and Noah Roberson. "DO & CO: Crafting Luxury in the Fast Lane (A)." Harvard Business School Case 724-416, January 2024. (Revised October 2024.)
- 04 Aug 2009
- First Look
First Look: August 4
Working PapersThe Impact of Private Equity Ownership on Corporate Tax Avoidance Authors:Brad Badertscher, Sharon P. Katz, and Sonja Olhoft Rego Abstract This study investigates how private equity ownership affects View Details
Keywords: Martha Lagace
- 19 May 2011
- Research & Ideas
Empathy: The Brand Equity of Retail
There's a famous line from the movie The Godfather, which is often repeated in corporate settings: "This is business, not personal." Ironically, though, that statement is actually bad business advice. During the Consortium for Operational... View Details
- 19 Jan 2022
- In Practice
7 Trends to Watch in 2022
As 2022 gets underway we asked our faculty to highlight some trends worth watching in the coming year. Ariel Stern: A new future for digital health care While 2020 and 2021 were years of rapid innovation and deployment of new health care technologies and delivery... View Details
Keywords: by HBS News
- April 2024 (Revised July 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details
Keywords: Cost vs Benefits; Decisions; Judgments; Values and Beliefs; Global Strategy; Health Care and Treatment; Patents; Growth and Development Strategy; Growth Management; Product Positioning; Supply and Industry; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Philanthropy and Charitable Giving; Opportunities; Social Issues; Equality and Inequality; Health Industry; Health Industry; Denmark; United States; Europe; China; India; Middle East; North Africa
Badaracco, Joseph L., Tom Quinn, and John Schultz. "Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs." Harvard Business School Case 324-114, April 2024. (Revised July 2024.)